Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 18, 2021 08:00 ET | Source: OncXerna Therapeutics, Inc.

OncXerna Therapeutics to Present at Jefferies Virtual Healthcare Conference

WALTHAM, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to...
April 10, 2021 08:30 ET | Source: OncXerna Therapeutics, Inc.

OncXerna Therapeutics Provides New Results from its Xerna™ RNA-based Biomarker Platform at the AACR Annual Meeting

Xerna™ TME Panel describes the tumor microenvironment based on dominant biology subtypes with prognostic capabilities in colorectal cancer Data supports the application of Xerna™ TME Panel beyond...
February 12, 2021 07:05 ET | Source: OncXerna Therapeutics, Inc.

OncXerna Therapeutics to Participate at the Upcoming Investor Conferences

WALTHAM, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker platform to potentially predict patient responses...
January 29, 2021 07:05 ET | Source: OncXerna Therapeutics, Inc.

OncXerna Therapeutics Appoints Colleen Mockbee as Chief Development Officer and Senior Vice President of Regulatory Affairs

WALTHAM, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker platform to potentially predict patient responses...
November 13, 2020 07:05 ET | Source: OncXerna Therapeutics, Inc.

OncXerna Therapeutics to Participate at the Piper Sandler Virtual Healthcare Conference

WALTHAM, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker platform to predict patient responses for...
October 15, 2020 07:10 ET | Source: OncXerna Therapeutics, Inc.

OncXerna Therapeutics to Participate at the Jefferies Virtual London Healthcare Conference

WALTHAM, Mass., Oct. 15, 2020 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker platform to predict patient responses for...
September 18, 2020 07:05 ET | Source: OncXerna Therapeutics, Inc.

Oncologie Announces New Data and Analyses from Clinical Programs and Name Change to OncXerna Therapeutics

OncXerna’s RNA-based biomarker platform successfully identified responders versus non-responders in trials with late-stage cancer patients Interim results from a Phase 2 trial of bavituximab with...
August 27, 2020 07:05 ET | Source: Oncologie, Inc.

Oncologie Announces Presentation at the Morgan Stanley Annual Global Healthcare Conference

WALTHAM, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Oncologie, Inc., a precision medicine company using an innovative RNA-based biomarker platform to develop novel, targeted oncology therapies, today...
July 27, 2020 16:15 ET | Source: Oncologie, Inc.

Oncologie Announces Upcoming Presentations at Investor Conferences

WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Oncologie, Inc., a precision medicine company using an innovative RNA-based biomarker platform to develop novel, targeted oncology therapies, today...
July 09, 2020 07:00 ET | Source: Oncologie, Inc.

Oncologie Expands and Strengthens Management Team with Key Appointments and Promotions

-Appoints Matthew Osborne as Chief Financial Officer- -Names Hagop Youssoufian, M.D., as Interim Chief Medical Officer- -Hires Bill McDonald, Ph.D., as Vice President of CMC- -Promotes Kerry...